Media & Analysis

News
David Munis Zepernick

David Munis Zepernick

Head of Business Development and Public Affairs

Below you will find the latest news from MVA. You can also sign up to our newsletter MVA Update.

MVA Update is an electronic newsletter providing you with news about MVA and an overview of our events and other relevant events in Medicon Valley. You can also check out our calendar for more information about life science events in the region.

If you have any questions regarding our news section or media inquiries then please contact David Munis Zepernick, Head of Press on +45 2498 1668.

Next deadline for Bioinnovation Institute´s Creation House program is 23rd of February

MVA-member, BioInnovation Institute´s, 18-months Creation House Program is for companies with a solid, initial business plan aiming to build a case that can attract substantial funding. In the therapeutic area, a cellular proof of concept with chemical or biological tool compounds is required. In bioindustrials, a proof of concept on MVP is required and in health tech, a scale-up ready MVP is required. In collaboration with the BII team and their network of experts, you will make a...

Become a mentor with University of Copenhagens “The BRIDGE – Translational Excellence Programme”

The BRIDGE - Translational Excellence Programme offers a few select graduated PhDs a two-year postdoctoral fellowship in translational medicine. A BRIDGE fellowship is a unique postdoctoral programme consisting of three core elements: education, mentoring and research. As a mentor in the BRIDGE programme you have a unique opportunity to start or consolidate a collaboration between a basic biomedical and a clinical research or life science industry environment. Recruitment of an excellent...

Any national life science strategy – Danish or Swedish – should aspire to realize the full potential of the bi-national Medicon Valley life science cluster

In the life science magazine distributed with Danish daily, Berlingske, Friday, Medicon Valley Alliance Chairman of the Board of Directors, Søren Bregenholt, strongly emphasizes the potential of the Medicon Valley life science cluster, which any national life science strategy - Danish or Swedish - with Nordic and international ambitions should aspire to realize. Read the contribution (in Danish) from Søren Bregenholt here. The full magazine including must read inputs from among others key MVA...

Key South Swedish life science stakeholders call for targeted investment in pandemic related R&D

In today´s edition of Dagens Medicin Sweden, a handful of key stakeholders in South Swedish life science, including MVA CEO, Petter Hartman, call for the Swedish government to prioritize pandemic-related R&D, focus on on Sweden as an attractive destination for clinical trials and improve the framework conditions for the commercialisation of life science R&D for small and medium-sized companies. The other co-authors of the opinion piece (in Swedish) are: Christina Östberg Lloyd, CEO,...

12 Biotech-Themed Online Courses to Try at Home During Lockdown

There is an opportunity in every calamity, as the famous Churchill quote goes! Perhaps now you have time for some of the many free online courses about the biotech industry and how to run a business in this exciting field? Our friends at Labiotech.eu have published an updated list of highly recommended free European online course of relevance for the industry. Among the distinguished providers highlighted such as MIT in Cambridge, Massachusetts, US, University of California, San Diego, US and...

Approximately 20 Skåne-based life science companies have a Danish CEO

Life science in Skåne and Denmark  - the Medicon Valley cluster - is increasingly interconnected, MVA CEO, Petter Magnusson Hartman, points out in a Medwatch interview about the recently published MVA-Øi-survey, Life Science in Skåne. There are for instance about 20 Danish CEO´s in Skåne-based life science companies. Ascelia Pharma (Magnus Corfitzen, photo), Atos Medical (Britt Meelby Jensen) and Hansa Biopharma (Søren Tulstrup) are just some of the more well-known examples. Read the full...

Capital injection for Danish-Swedish diabetes research

Sweden and Denmark are among the countries in the world hardest hit by type 1 diabetes. The DiaUnion project now receives an additional EUR 1 million funding to investigate the link between type 1 diabetes and related autoimmune diseases.    Type 1 diabetes causes the immune system to attack and destroy the body’s own vital insulin-producing cells. The disease is chronic and typically affects children and adolescents. In Sweden, about 50,000 people live with type 1 diabetes, and the situation...

Life science in Skåne is doing good

If you want to know exactly how good, please download the survey published and presented today at Malmoe City Hall by ØresundsInstituttet and Medicon Valley Alliance. Skåne is increasingly becoming the bridge between Danish and Swedish life science and a force to be reckoned when dealing with national life science strategies in both countries. The survey is co-funded by Interreg Öresund-Kattegat-Skagerrak

Download the brand new 2020 State of Medicon Valley Analysis free of charge

What is the State of the Danish-Swedish life science cluster, Medicon Valley? What is the contribution of life science to the Danish and Swedish economy respectively? How much is life science in Medicon Valley contributing to employment? How does Medicon Valley rank compared to other European life science clusters? What are the obstacles for future development? How to we realise the full potential of the Medicon Valley life science cluster? What is the role of Medicon Valley based life science...